Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Revenues:
Earned premiums	$ 3,911,718	$ 2,671,931	$ 1,800,933
Other	37,001	31,630	22,697
Total revenues	3,948,719	2,703,561	1,823,630
Expenses:
Medical expenses	3,460,156	2,406,870	1,622,600
Selling, general, and administrative expenses	443,407	371,374	307,433
Depreciation and amortization	30,404	26,872	21,414
Total expenses	3,933,967	2,805,116	1,951,447
Income (loss) from operations	14,752	(101,555)	(127,817)
Other expenses:
Interest expense	15,799	23,547	21,231
Other income, net	(89)	(72)	(853)
Loss on extinguishment of debt	0	3,020	0
Total other expenses	15,710	26,495	20,378
Loss before income taxes	(958)	(128,050)	(148,195)
Total	20	21	(22)
Net loss	(978)	(128,071)	(148,173)
Less: Net loss attributable to noncontrolling interest	(254)	(36)	(156)
Net loss attributable to Alignment Healthcare, Inc.	$ (724)	$ (128,035)	$ (148,017)
Total weighted-average common shares outstanding - basic (in shares)	198,006,216	190,793,552	186,214,784
Total weighted-average common shares outstanding - diluted (in shares)	198,006,216	190,793,552	186,214,784
Net loss per share attributable to Alignment Healthcare, Inc. - basic (in dollars per share)	$ 0.00	$ (0.67)	$ (0.79)
Net loss per share attributable to Alignment Healthcare, Inc. - diluted (in dollars per share)	$ 0.00	$ (0.67)	$ (0.79)